Study of the Efficacy and Safety of Apricitabine, a New NRTI, to Treat Drug-resistant HIV Infection
Clinical trial NCT00612898 · TERMINATED
Trial details
- NCT number
- NCT00612898
- Sponsor
- Avexa
- Status
- TERMINATED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-02-01
- Primary completion
- 2010-01-01
- Enrollment
- 239
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.